2023 June Inhalation HW Boston

Asmita Khanolkar
Senior Director, Cambridge Pharma

Is this your profile?

About

Asmita Khanolkar is Asmita Khanolkar is Senior Director for Cambridge Pharma (part of SMC Ltd). She has a master’s degree in Materials Science & Engineering from Worcester Polytechnic Institute in Worcester (MA, US). With more than 25 years of manufacturing experience, specialising in the medical device and pharmaceutical industry, she has managed various device projects from concept to commercial launch.

Contributions

PREFILLED SYRINGES

ACCELERATING NOVEL THERAPIES TO THE CLINIC – CUSTOM SOLUTIONS

Asmita Khanolkar discusses the key offerings necessary to accelerate “speed to clinic” for custom manufacturing solutions.

More contributions

COMPUTATIONAL MODELLING OF INJECTION-RELATED TISSUE RESPONSES IN DRUG DELIVERY

Olivia Jefferies, Elizabeth Margerison and Asmita Khanolkar introduce Oval’s work on using ultrasound scanning and finite element analysis to construct a model of how tissue compresses under use of an autoinjector across patient demographics, and how this may provide insights into improved autoinjector design for more accurate injection depths, improving patient outcomes.

A NEW MINDSET FOR COMBINATION PRODUCT DEVELOPMENT

Asmita Khanolkar outlines the latest trends in combination product development to overcome some of the current challenges of high dose/viscosity/volume delivery.

PATIENT-CENTRICITY: THE IMPORTANCE OF HUMAN FACTORS IN THE PANDEMIC ERA

Marcus Agunloye and Asmita Khanolkar, Senior Director discuss how patient-centricity is at the heart of drug delivery device design and innovation, and how the global pandemic has highlighted the importance of patient-centric development in this field.

Top